Search results
Results From The WOW.Com Content Network
Top surgery involves more than a mastectomy for the treatment of breast cancer. [1] Special techniques are used to contour and reduce the chest wall, position the nipples and areola, and minimize scarring. [1] If the breast size is small, surgery that spares the skin, nipple and areola (subcutaneous nipple-sparing mastectomy) may be performed ...
v. t. e. Masculinizing hormone therapy, also known as transmasculine hormone therapy or female-to-male (or FTM) hormone therapy, is a form of hormone therapy and gender affirming therapy which is used to change the secondary sexual characteristics of transgender people from feminine or androgynous to masculine. [ 1][ 2][ 3] It is a common type ...
Gender-affirming surgery is a surgical procedure, or series of procedures, that alters a person's physical appearance and sexual characteristics to resemble those associated with their identified gender. The phrase is most often associated with transgender health care and intersex medical interventions, although many such treatments are also ...
Hereditary breast–ovarian cancer syndromes ( HBOC) are cancer syndromes that produce higher than normal levels of breast cancer, ovarian cancer and additional cancers in genetically related families (either one individual had both, or several individuals in the pedigree had one or the other disease). It accounts for 90% of the hereditary ...
v. t. e. Gender-affirming surgery for male-to-female transgender women or transfeminine non-binary people describes a variety of surgical procedures that alter the body to provide physical traits more comfortable and affirming to an individual's gender identity and overall functioning. Often used to refer to vaginoplasty, sex reassignment ...
Tumor marker. A tumor marker is a biomarker that can be used to indicate the presence of cancer or the behavior of cancers (measure progression or response to therapy). They can be found in bodily fluids or tissue. Markers can help with assessing prognosis, surveilling patients after surgical removal of tumors, and even predicting drug-response ...
Triple-negative breast cancer. Triple-negative breast cancer ( TNBC) is any breast cancer that either lacks or shows low levels of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) overexpression and/or gene amplification (i.e. the tumor is negative on all three tests giving the name triple ...
Ellis underwent genetic testing and learned she had a mutation to her BRCA1 gene, which increases the risk of breast cancer recurring, as well as developing ovarian cancer, according to the U.S ...